{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T05:30:05Z","timestamp":1736573405541,"version":"3.32.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.contraception.2024.110730","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T06:42:22Z","timestamp":1729838542000},"page":"110730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Symptomatic hypotensive episodes following Implanon NXT\u00a0insertion: A case report"],"prefix":"10.1016","volume":"142","author":[{"given":"Nicole A.","family":"Milanko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5479-171X","authenticated-orcid":false,"given":"Rajesh","family":"Gangaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.contraception.2024.110730_bib1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jpag.2010.03.006","article-title":"Implanon: the subdermal contraceptive implant","volume":"23","author":"Isley","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.contraception.2024.110730_bib2","unstructured":"AB, SS. Spotlight on Implanon and Mirena long-acting reversible contraceptives, as women report severe side-effects. [online]; 2017. October 17, 2024 \u3008https:\/\/www.abc.net.au\/news\/2017-12-12\/spotlight-on-mirena-and-implanon-contraceptive-devices\/9247960\u3009."},{"year":"2020","series-title":"Contraception in Australia 2005-2018","author":"Wright","key":"10.1016\/j.contraception.2024.110730_bib3"},{"issue":"6","key":"10.1016\/j.contraception.2024.110730_bib4","first-page":"337","article-title":"Etonogestrel (Implanon), another treatment option for contraception","volume":"33","author":"Maddox","year":"2008","journal-title":"Pharm Ther"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib5","first-page":"e2132","article-title":"Complications of subcutaneous contraception: a review","volume":"10","author":"Ramdhan","year":"2018","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.contraception.2024.110730_bib6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7196\/SAMJ.2019.v109i10.00012","article-title":"Reasons for requesting removal of the hormonal implant, Implanon NXT, at an urban reproductive health clinic in KwaZulu-Natal, South Africa","volume":"109","author":"Beesham","year":"2019","journal-title":"S Afr Med J"},{"issue":"2","key":"10.1016\/j.contraception.2024.110730_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0010-7824(93)90091-K","article-title":"Preliminary experience with Norplant in an inner city population","volume":"47","author":"Cullins","year":"1993","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib8","first-page":"21","article-title":"A study of the acceptability and effectiveness of Norplant (R) contraceptive implants in Kuala Lumpur, Malaysia","volume":"8","author":"Arshat","year":"1990","journal-title":"Malays J Reprod Health"},{"issue":"2","key":"10.1016\/j.contraception.2024.110730_bib9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2307\/2138114","article-title":"Acceptance, efficacy, and side effects of Norplant implants in four counties in north China","volume":"28","author":"Tu","year":"1997","journal-title":"Stud Fam Plann"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(93)90112-K","article-title":"One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant)","volume":"47","author":"Coutinho","year":"1993","journal-title":"Contraception"},{"issue":"5 Pt 1","key":"10.1016\/j.contraception.2024.110730_bib11","first-page":"673","article-title":"A 5-year evaluation of NORPLANT contraceptive implants in China","volume":"83","author":"Gu","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0010-7824(01)00289-X","article-title":"Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials","volume":"65","author":"Brache","year":"2002","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2024.110730_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200326050-00002","article-title":"Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants","volume":"26","author":"Sivin","year":"2003","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.contraception.2024.110730_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/13625180701548040","article-title":"Contraceptive efficacy and side effects of Implanon","volume":"12","author":"Gezginc","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"11","key":"10.1016\/j.contraception.2024.110730_bib15","first-page":"849","article-title":"Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal","volume":"41","author":"Haugen","year":"1996","journal-title":"J Reprod Med"},{"issue":"6","key":"10.1016\/j.contraception.2024.110730_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-199855060-00019","article-title":"Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability","volume":"55","author":"Coukell","year":"1998","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12978-021-01222-8","article-title":"Early implanon discontinuation and associated factors among women ever used implanon in Mettu district, Oromia regional state, Southwest Ethiopia, 2021","volume":"18","author":"Tesfaye","year":"2021","journal-title":"Reprod Health"},{"issue":"6","key":"10.1016\/j.contraception.2024.110730_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/ph14060548","article-title":"Safety and benefits of contraceptives implants: a systematic review","volume":"14","author":"Rocca","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.contraception.2024.110730_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jpag.2020.12.019","article-title":"Subdermal contraceptive implant insertion trends and retention in adolescents","volume":"34","author":"Tyson","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12978-020-01054-y","article-title":"A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant","volume":"18","author":"Moray","year":"2021","journal-title":"Reprod Health"},{"issue":"3","key":"10.1016\/j.contraception.2024.110730_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpag.2016.12.006","article-title":"\u2018\u2018Just Wear Dark Underpants Mainly\": learning from adolescents' and young adults' experiences with early discontinuation of the contraceptive implant","volume":"30","author":"Lunde","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110730_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpag.2016.08.003","article-title":"Etonogestrel-releasing contraceptive implant for postpartum adolescents: a randomized controlled trial","volume":"30","author":"Bryant","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2024.110730_bib23","first-page":"522","article-title":"Evaluation of long-acting contraceptive (implant) acceptance, utilization, and discontinuation in Huambo and Luanda, Angola","volume":"82","author":"Qiu","year":"2016","journal-title":"Ann\u00a0Glob\u00a0Health"},{"issue":"sup1","key":"10.1016\/j.contraception.2024.110730_bib24","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.3109\/13625187.2014.894779.06","article-title":"Abstracts of WHO symposium","volume":"19","author":"Brache","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13625180801960012","article-title":"Tolerability and clinical safety of Implanon","volume":"13","author":"Blumenthal","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.contraception.2024.110730_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/13625180701442228","article-title":"Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey","volume":"12","author":"Yildizbas","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.contraception.2024.110730_bib27","first-page":"314","article-title":"One year study of Implanon on the adverse events and discontinuation","volume":"88","author":"Chaovisitsaree","year":"2005","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"10.1016\/j.contraception.2024.110730_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.contraception.2003.10.019","article-title":"Norplant insertions at the Zeynep Kamil Gynecologic and Pediatric Training Research Hospital in Istanbul","volume":"69","author":"Tugrul","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2024.110730_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/13625180400017503","article-title":"Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group","volume":"9","author":"Bitzer","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2024.110730_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.HYP.37.1.142","article-title":"Vascular effects of progesterone: role of cellular calcium regulation","volume":"37","author":"Barbagallo","year":"2001","journal-title":"Hypertension"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424004396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424004396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T15:19:13Z","timestamp":1736522353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":30,"alternative-id":["S0010782424004396"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110730","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic hypotensive episodes following Implanon NXT\u00a0insertion: A case report","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110730"}}